Tuesday, December 2, 2008 - 4:26PM EST

Clinical Trials

18. Sjogren's syndrome is associated with and not secondary to systemic sclerosis.

Author
Salliot C; Mouthon L; Ardizzone M; Sibilia J; Guillevin L; Gottenberg JE; Mariette X;
Institution
Rheumatology Department, Paris-Sud 11 University, INSERM U802, France.
Journal
Rheumatology (Oxford). 2007 Feb;46(2):321-6. Epub 2006 Jul 28.
Abstract URL
Click here to view abstract

19. Suspension made with amniotic membrane: clinical trial.

Author
Bonci, P; Bonci, P; Lia, A;
Institution
Department of Ophthalmology, Eye Bank, S. Maria della Scaletta Hospital, Imola (BO) - Italy.
Journal
Eur J Ophthalmol 2005 Jul-Aug;15(4):441-5.
Abstract URL
Click here to view abstract

20. Effect of cevimeline on salivary components in patients with Sjogren syndrome.

Author
Suzuki, Kimihiro; Matsumoto, Mitsuyo; Nakashima, Masahiro; Takada, Kunio; Nakanishi, Takashi; Okada, Makoto; Ohsuzu, Fumitaka;
Institution
Internal Medicine I, National Defense Medical College, Tokorozawa, Japan. kogen@me.ndmc.ac.jp
Journal
Pharmacology 2005 May;74(2):100-5. Epub 2005 Feb 18.
Abstract URL
Click here to view abstract

21. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren's syndrome patients.

Author
Aragona, P; Stilo, A; Ferreri, F; Mobrici, M;
Institution
Department of Surgical Science, Section of Ophthalmology, University of Messina, Messina, Italy. paragona@unime.it
Journal
Eye 2005 May;19(5):535-9.
Abstract URL
Click here to view abstract
Pages: 1 2 3